Skip to main content
SpringerLink
Log in

Breast Cancer Trends in Women in Sweden, the UK, and the USA in Relation to Their Past Use of Oral Contraceptives

  • Conference paper
Hormonal Carcinogenesis II

Abstract

Since their introduction in the early 1960’s, oral contraceptives (OCs) have become one of the most popular methods of contraception. They have been used by an estimated 67 million women in developed countries and 200 million women worldwide (International Planned Parenthood Federation, personal communication). Reports that OC use might increase the risk of breast cancer came first from California (1), and subsequently from Sweden and Norway (2), the UK (3), and elsewhere in the USA (4). However, the results of many other studies, particularly those that included older women, did not suggest an increase in breast cancer risk (5). Nevertheless, some have expressed concern that the use of OCs at an early age, especially before the birth of the first child, may lead to an increase in the risk of breast cancer when women reach middle-age (6).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pike MC, Henderson BE, Krailo MD et al (1983) Breast cancer in young women and use of oral contraceptives. Possible modifying effects of formulation and age at use. Lancet II: 926–930.

    Article  Google Scholar 

  2. Meirik O, Adami H-O, Christoffersen T et al (1986) Oral contraceptive use and breast cancer in young women. Lancet II: 650–653.

    Article  Google Scholar 

  3. UK National Case-Control Study Group (1989) Oral contraceptive use and breast cancer risk in young women. Lancet I: 973–982.

    Google Scholar 

  4. White E, Malone KE, Weiss NS, Daling JR (1994) Breast cancer among young US women in relation to oral contraceptive use. J Natl Cancer Inst 86: 505–514.

    Article  PubMed  CAS  Google Scholar 

  5. Wingo PA, Lee NC, Ory HW et al (1991) Age-specific differences in the relationship between oral contraceptive use and breast cancer. Obst Gynecol 78: 161–170.

    CAS  Google Scholar 

  6. McPherson K (1993) Childbearing, oral contraceptive use and breast cancer. Lancet 341: 1604.

    Article  PubMed  CAS  Google Scholar 

  7. Lund E, Meirik O, Adami H-0 et al (1989) Oral contraceptive use and premenopausal breast cancer in Sweden and Norway: Possible effects of different pattern of use. Int J Epidemiology 18: 527–532.

    Article  CAS  Google Scholar 

  8. Thorogood M, Vessey MP (1990) Trends in use of oral contraceptives in Britain. Brit J Family Planning 16: 41–53.

    Google Scholar 

  9. Werner B, Chalk S (1986) Projections of first, second, third and later births. Population Trends 45: 26–34.

    Google Scholar 

  10. Tarone RE, Chu KC (1992) Implications of birth cohort patterns in interpreting trends in breast cancer rates. J Natl Cancer Inst 84: 1402–1410.

    Article  PubMed  CAS  Google Scholar 

  11. Early Breast Cancer Trialists’ Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 1–15.

    Google Scholar 

  12. Doll R, Peto R (1981) The causes of cancer. J Natl Cancer Inst 66: 1191–1308.

    PubMed  CAS  Google Scholar 

  13. Peto R, Lopez AD, Boreham J et al (1994) Mortality from smoking in developed countries 1950–2000. Oxford University Press. Oxford.

    Google Scholar 

Download references

Authors
  1. Valerie Beral
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carol Hermon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gillian Reeves
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Timothy Key
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Etiology and Prevention of Hormonal Cancers, Hormonal Carcinogenesis Laboratory, University of Kansas Cancer Center, Kansas City, Kansas, USA

    J. Jonathan Li Ph.D. (Professor of Pharmacology, Toxicology, and Therapeutics, Director) (Professor of Pharmacology, Toxicology, and Therapeutics, Director)

  2. Hormonal Carcinogenesis Laboratory, University of Kansas Cancer Center, Kansas City, Kansas, USA

    Sara Antonia Li Ph.D. (Associate Professor of Pharmacology, Toxicology, and Therapeutics) (Associate Professor of Pharmacology, Toxicology, and Therapeutics)

  3. Department of Medical Nutrition, Center for Biotechnology, NOVUM, Huddinge University Hospital, Huddinge, Sweden

    Jan-Åke Gustafsson M.D., Ph.D. (Professor and Chairman, Director) (Professor and Chairman, Director)

  4. Department of Molecular and Cell Biology, Cancer Research Center, University of California, Berkeley, California, USA

    Satyabrata Nandi Ph.D. (Professor of Cell and Development Biology) (Professor of Cell and Development Biology)

  5. Division of Cancer Etiology, Chemical and Physical Carcinogenesis Program, National Cancer Institute, Rockville, Maryland, USA

    Lea I. Sekely Ph.D. (Program Director) (Program Director)

  6. University of Kansas Medical Center, Kansas City, Kansas, USA

    J. Jonathan Li Ph.D. (Professor of Pharmacology, Toxicology, and Therapeutics, Director) & Sara Antonia Li Ph.D. (Associate Professor of Pharmacology, Toxicology, and Therapeutics) (Professor of Pharmacology, Toxicology, and Therapeutics, Director) &  (Associate Professor of Pharmacology, Toxicology, and Therapeutics)

  7. National Institutes of Health, Rockville, Maryland, USA

    Lea I. Sekely Ph.D. (Program Director) (Program Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag New York, Inc.

About this paper

Cite this paper

Beral, V., Hermon, C., Reeves, G., Key, T. (1996). Breast Cancer Trends in Women in Sweden, the UK, and the USA in Relation to Their Past Use of Oral Contraceptives. In: Li, J.J., Li, S.A., Gustafsson, JÅ., Nandi, S., Sekely, L.I. (eds) Hormonal Carcinogenesis II. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2332-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2332-0_11

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7506-0

  • Online ISBN: 978-1-4612-2332-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation